Israel Glucose Monitoring Devices Market, By Product (Self-Monitoring Glucose Devices, Continuous Glucose Monitoring Devices), By Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), By End User (Home Care Settings, Hospital, and Othe

Israel Glucose Monitoring Devices Market, By Product (Self-Monitoring Glucose Devices, Continuous Glucose Monitoring Devices), By Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), By End User (Home Care Settings, Hospital, and Others), By Region, Competition, Forecast & Opportunities, 2028

Israel Glucose Monitoring Devices Market is expected to grow at an impressive rate during the forecast period. The country is witnessing a growing demand for glucose monitoring devices due to the increasing prevalence of diabetes. Advancements in technologies, rising healthcare expenditure, and growing awareness about diabetes are also supporting the Israel glucose monitoring devices market.

The market is witnessing significant technological advancements. New devices are being developed that are more accurate, reliable, and user-friendly. For example, continuous glucose monitoring (CGM) devices are becoming increasingly popular in Israel, as they provide real-time glucose readings and allow people to monitor their glucose levels continuously.

There is a growing awareness about diabetes in Israel, which is leading to an increase in the demand for glucose monitoring devices. People are becoming more aware of the importance of monitoring their blood glucose levels regularly and are taking proactive steps to manage their condition effectively.

While the glucose monitoring devices market in Israel is growing, several factors may hamper its growth in the coming years. These factors include limited healthcare infrastructure, high cost of devices, lack of awareness about effective management of diabetes, limited reimbursement policies, and limited availability of devices. The cost of glucose monitoring devices can be high, especially for advanced devices, such as continuous glucose monitoring (CGM) systems. This high cost can limit the market’s growth, as people may not be able to afford the devices, especially those with limited financial resources.

While there is growing awareness about diabetes in Israel, many people still lack adequate knowledge about the condition and how to manage it effectively. This lack of awareness can also limit the market's growth, as people may not see the need to monitor their blood glucose levels regularly or may not understand the benefits of using glucose monitoring devices.

The geriatric population in Israel is continuously rising, and older adults are at a higher risk of developing diabetes. This growing population is expected to drive the demand for glucose monitoring devices in the coming years, as older adults need to monitor their blood glucose levels regularly to manage their condition effectively.

Mobile applications are becoming increasingly popular in the glucose monitoring devices market. These applications can help people with diabetes track their blood glucose levels, record insulin doses, and monitor other health metrics. Mobile applications are user-friendly, easy to access, and can provide real-time information to people with diabetes, which is expected to drive their demand in the coming years.

Artificial Intelligence (AI) is also playing a significant role in the growth of the glucose monitoring devices market in Israel. AI algorithms can analyze glucose data and provide personalized insights to people with diabetes. These insights can help people with diabetes manage their condition more effectively and prevent complications. AI-powered glucose monitoring devices are expected to become increasingly popular in Israel in the coming years.

Wearable devices are another technological advancement that is driving the glucose monitoring devices market in Israel. These devices can be worn on the body and can provide real-time glucose readings, similar to CGM systems. Wearable devices are user-friendly, easy to access, and can provide people with diabetes with more flexibility in monitoring their blood glucose levels.

Increasing Prevalence of Diabetes

The prevalence of diabetes in Israel is one of the primary factors driving the growth of this market. One of the top ten primary causes of death worldwide is diabetes mellitus (DM). Diabetes mellitus is becoming more prevalent, which has a significant negative impact on both financial and physical well-being. According to the WHO, published in 2020, Israel touched 1913 deaths by Diabetes Mellitus, which is 5.44% of total deaths in the country. Diabetes mellitus (DM) is characterized as a chronic condition of carbohydrate metabolism brought on by inadequate or unresponsive insulin secretion. Type 1 DM, type 2 DM (which is the most prevalent), and gestational DM are the three main forms. Micro- and macrovascular consequences from long-term untreated DM can increase morbidity and mortality in diabetics.

The prevalence of diabetes in Israel is expected to continue to increase in the coming years due to several factors, including lifestyle changes, urbanization, and an aging population. As the number of people living with diabetes in Israel increases, so does the demand for glucose-monitoring devices. Glucose monitoring devices are essential for people with diabetes to manage their condition effectively. They allow people with diabetes to monitor their blood glucose levels regularly and adjust their treatment plan accordingly. Without regular monitoring, people with diabetes are at risk of developing complications, such as blindness, kidney failure, and cardiovascular diseases.

Growing Awareness Regarding Diabetes Mellitus

Growing awareness regarding diabetes mellitus is driving the glucose monitoring devices market in Israel in the coming years. There are several education and awareness campaigns aimed at informing people about diabetes mellitus and its management. These campaigns are designed to educate people on the importance of blood glucose monitoring, healthy lifestyle changes, and the use of glucose monitoring devices in managing diabetes. These awareness campaigns are driving demand for glucose monitoring devices in Israel, as more people are becoming aware of the importance of using these devices to manage their diabetes.

Healthcare professionals play a vital role in raising awareness of diabetes mellitus and glucose monitoring devices in Israel. Doctors, nurses, and other healthcare professionals are recommending glucose monitoring devices to their patients to help them manage their diabetes effectively. This is driving demand for glucose monitoring devices in Israel, as more people are following their healthcare professional's advice and using these devices.

Technological Advancements

There have been several technological advancements in glucose monitoring devices in Israel in recent years. One of the most significant advances is the introduction of continuous glucose monitoring (CGM) devices, which allow for continuous and automatic tracking of blood glucose levels. These devices have proven to be particularly useful for people with type 1 diabetes, as they can help prevent severe hypoglycemia and hyperglycemia by alerting users to changes in their glucose levels in real time. Another advancement is the development of non-invasive glucose monitoring devices, which use infrared light or ultrasound to measure glucose levels without the need for a fingerstick. These devices are particularly useful for people who are uncomfortable with the traditional fingerstick method or have difficulty performing it themselves. Additionally, mobile applications have been developed that allow for remote monitoring of glucose levels, enabling healthcare professionals and caregivers to keep track of patients' glucose levels in real-time. These technological advancements have made it easier and more convenient for people to monitor their blood glucose levels and manage their diabetes effectively.

Market Segmentation

The Israel glucose monitoring devices market can be segmented by product, application, end user, and region. By product, the market can be segmented into self-monitoring glucose devices and continuous glucose monitoring devices. Based on application, the market is divided into Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. Based on end user, the market is divided into home care settings, hospital, and others.

Market Players

Roche Israel, Abbott Diagnostics, MEDTRONIC ISRAEL LLC., Johnson & Johnson, LifeScan Israel, and Ascensia Diabetes Care are some of the leading companies operating in the market.

Report Scope:

In this report, the Israel glucose monitoring devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Israel Glucose Monitoring Devices Market, By Product
• Self-Monitoring Glucose Devices
• Continuous Glucose Monitoring Devices
• Israel Glucose Monitoring Devices Market, By Application
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Israel Glucose Monitoring Devices Market, By End User
• Home Care Settings
• Hospital
• Others

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Israel glucose monitoring devices market.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights